205 related articles for article (PubMed ID: 28735667)
1. Immunohistochemical Expression of MCAM/CD146 in Canine Melanoma.
Abou Asa S
J Comp Pathol; 2017 Jul; 157(1):27-33. PubMed ID: 28735667
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical analysis of CD146 expression in canine skin tumours.
Abou Asa S; Anwar Sh; Yanai T; Sakai H
Histol Histopathol; 2016 Apr; 31(4):453-9. PubMed ID: 26573287
[TBL] [Abstract][Full Text] [Related]
3. Cyclooxygenase-2 expression is associated with infiltration of inflammatory cells in oral and skin canine melanomas.
Silveira TL; Veloso ES; Gonçalves INN; Costa RF; Rodrigues MA; Cassali GD; Del Puerto HL; Pang LY; Argyle DJ; Ferreira E
Vet Comp Oncol; 2020 Dec; 18(4):727-738. PubMed ID: 32323423
[TBL] [Abstract][Full Text] [Related]
4. Sequential molecular analysis of circulating MCAM/MUC18 expression: a promising disease biomarker related to clinical outcome in melanoma.
Rapanotti MC; Suarez Viguria TM; Costanza G; Ricozzi I; Pierantozzi A; Di Stefani A; Campione E; Bernardini S; Chimenti S; Orlandi A; Bianchi L
Arch Dermatol Res; 2014 Aug; 306(6):527-37. PubMed ID: 24902661
[TBL] [Abstract][Full Text] [Related]
5. Galectin-3 Is a Natural Binding Ligand of MCAM (CD146, MUC18) in Melanoma Cells and Their Interaction Promotes Melanoma Progression.
Pang Y; Maxwell E; Sindrewicz-Goral P; Shapanis A; Li S; Morgan M; Yu LG
Biomolecules; 2022 Oct; 12(10):. PubMed ID: 36291660
[TBL] [Abstract][Full Text] [Related]
6. MCAM/MUC18/CD146 as a Multifaceted Warning Marker of Melanoma Progression in Liquid Biopsy.
Rapanotti MC; Cugini E; Nuccetelli M; Terrinoni A; Di Raimondo C; Lombardo P; Costanza G; Cosio T; Rossi P; Orlandi A; Campione E; Bernardini S; Blot-Chabaud M; Bianchi L
Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830300
[TBL] [Abstract][Full Text] [Related]
7. MUC18/MCAM (CD146), an activation antigen of human T lymphocytes.
Pickl WF; Majdic O; Fischer GF; Petzelbauer P; Faé I; Waclavicek M; Stöckl J; Scheinecker C; Vidicki T; Aschauer H; Johnson JP; Knapp W
J Immunol; 1997 Mar; 158(5):2107-15. PubMed ID: 9036955
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the diagnostic utility of MCAM-1 (CD146) in a group of common gynecological cancers: A case-control study.
Kumar A; Khurana U; Chowdhary R; Halder A; Kapoor N
Turk J Obstet Gynecol; 2024 Mar; 21(1):43-50. PubMed ID: 38440967
[TBL] [Abstract][Full Text] [Related]
9. Ectopic expression of MCAM/MUC18 increases in vitro motility and invasiveness, but decreases in vivo tumorigenesis and metastasis of a mouse melanoma K1735-9 subline in a syngeneic mouse model.
Wu GJ
Clin Exp Metastasis; 2016 Dec; 33(8):817-828. PubMed ID: 27510563
[TBL] [Abstract][Full Text] [Related]
10. Dual role of melanoma cell adhesion molecule (MCAM)/CD146 in lymphocyte endothelium interaction: MCAM/CD146 promotes rolling via microvilli induction in lymphocyte and is an endothelial adhesion receptor.
Guezguez B; Vigneron P; Lamerant N; Kieda C; Jaffredo T; Dunon D
J Immunol; 2007 Nov; 179(10):6673-85. PubMed ID: 17982057
[TBL] [Abstract][Full Text] [Related]
11. Stratification of patients by melanoma cell adhesion molecule (MCAM) expression on the basis of risk: implications for sentinel lymph node biopsy.
Pearl RA; Pacifico MD; Richman PI; Wilson GD; Grover R
J Plast Reconstr Aesthet Surg; 2008; 61(3):265-71. PubMed ID: 17569608
[TBL] [Abstract][Full Text] [Related]
12. Pro- and anti-tumour activities of CD146/MCAM in breast cancer result from its heterogeneous expression and association with epithelial to mesenchymal transition.
Mannion AJ; Odell AF; Baker SM; Matthews LC; Jones PF; Cook GP
Front Cell Dev Biol; 2023; 11():1129015. PubMed ID: 37138793
[TBL] [Abstract][Full Text] [Related]
13. Fascin-1 expression in canine cutaneous and oral melanocytic tumours.
Yamada N; Mori T; Murakami M; Noguchi S; Sakai H; Akao Y; Maruo K
Vet Comp Oncol; 2012 Dec; 10(4):303-11. PubMed ID: 22236355
[TBL] [Abstract][Full Text] [Related]
14. Melanoma cell adhesion molecule (MCAM/CD146) is expressed on human luteinizing granulosa cells: enhancement of its expression by hCG, interleukin-1 and tumour necrosis factor-alpha.
Yoshioka S; Fujiwara H; Higuchi T; Yamada S; Maeda M; Fujii S
Mol Hum Reprod; 2003 Jun; 9(6):311-9. PubMed ID: 12771231
[TBL] [Abstract][Full Text] [Related]
15. Melanoma progression-associated glycoprotein MUC18/MCAM mediates homotypic cell adhesion through interaction with a heterophilic ligand.
Johnson JP; Bar-Eli M; Jansen B; Markhof E
Int J Cancer; 1997 Nov; 73(5):769-74. PubMed ID: 9398060
[TBL] [Abstract][Full Text] [Related]
16. Galectin-3 Expression Correlates with Post-surgical Survival in Canine Oral Melanomas.
Vargas THM; Pulz LH; Ferro DG; Sobral RA; Venturini MAFA; Corrêa HL; Strefezzi RF
J Comp Pathol; 2019 Nov; 173():49-57. PubMed ID: 31812173
[TBL] [Abstract][Full Text] [Related]
17. Influence of MUC18/MCAM/CD146 expression on human melanoma growth and metastasis in SCID mice.
Schlagbauer-Wadl H; Jansen B; Müller M; Polterauer P; Wolff K; Eichler HG; Pehamberger H; Konak E; Johnson JP
Int J Cancer; 1999 Jun; 81(6):951-5. PubMed ID: 10362144
[TBL] [Abstract][Full Text] [Related]
18. Identification of the elements regulating the expression of the cell adhesion molecule MCAM/MUC18. Loss of AP-2 is not required for MCAM expression in melanoma cell lines.
Mintz-Weber CS; Johnson JP
J Biol Chem; 2000 Nov; 275(44):34672-80. PubMed ID: 10938273
[TBL] [Abstract][Full Text] [Related]
19. Lack of prognostic significance of angiogenesis in canine melanocytic tumours.
Cuitiño MC; Massone AR; Idiart JR
J Comp Pathol; 2012; 147(2-3):147-52. PubMed ID: 22520819
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical expression of MDR1-Pgp 170 in canine cutaneous and oral melanomas: pattern of expression and association with tumour location and phenotype.
Finotello R; Monné Rodriguez JM; Vilafranca M; Altimira J; Ramirez GA; Haines A; Ressel L
Vet Comp Oncol; 2017 Dec; 15(4):1393-1402. PubMed ID: 27779366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
